NSE: PARKHOSPS · BSE: 544645 · ISIN INE119201023
Park Medi World Limited stock analysis
Park Medi World Limited ranks #462 in the TickerSutra evidence-ranked universe with a score of 64/100 and 87% data confidence. The latest captured fundamentals show ROCE of 19.5%, quarterly sales growth of 19.3% and quarterly profit growth of 42.3%.Monitor only
INVESTMENT EVIDENCE
What supports—and challenges—the thesis
Evidence in favour
- Low debt/equity of 0.18×
- Institutional ownership is rising
- CWIP indicates an active capacity pipeline
- No promoter shares are reported as pledged
Risks and constraints
- Valuation is above 40× earnings
Still unresolved: Related-party exposure · Broad media sentiment
FINANCIAL TRAJECTORY
Recent operating history
| Period | Revenue | Operating profit | Net profit | Operating margin |
|---|---|---|---|---|
| 2022 | ₹1,084cr | ₹345cr | ₹199cr | 32.0% |
| 2023 | ₹1,255cr | ₹391cr | ₹228cr | 31.0% |
| 2024 | ₹1,231cr | ₹312cr | ₹152cr | 25.0% |
| 2025 | ₹1,394cr | ₹374cr | ₹215cr | 27.0% |
| 2026 | ₹1,679cr | ₹446cr | ₹274cr | 27.0% |
| TTM | ₹1,756cr | ₹466cr | ₹297cr | 27.0% |
EXCHANGE EVENT TRIGGERS
Latest corporate disclosures
Park Medi World Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
RoutineShareholders meetingNSE · 22 Sept 2026Park Medi World Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 22, 2026. Further, the company has informed the Exchange regarding voting results.
RoutinePark Medi World Ltd - 544645 - Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportBSE · 22 Sept 2026Voting Results and Consolidated Scrutinizer''s Report on E-voting at 15th Annual General Meeting held on September 22, 2026
RoutinePark Medi World Ltd - 544645 - Shareholder Meeting / Postal Ballot-Outcome of AGMBSE · 22 Sept 2026Summary of the proceedings of 15th Annual General Meeting of the Company held on September 22, 2026
RoutinePark Medi World Ltd - 544645 - Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseBSE · 22 Sept 2026Park Medi World Limited has informed the Exchange regarding a press release dated September 22, 2026, titled "Park Group of Hospitals Wins Three Honours at Healthcare Pioneers of Delhi 2026".
MANAGEMENT COMMENTARY
Signals from filed documents
Sudesh Sharma: Too early to comment on that. You are right, we have a three -year regulatory timeline which lapses in December 2028. We have barely completed 10 months, nine months since we got listed on the 17th of December.
PAT for the quarter was Rs.89 crores, with a PAT margin of 18.6%, an expansion of 220 basis points year-on-year. PAT margin expansion was largely on account of reduction in interest outgo following the substantial repayment of term debt over the past year. On the balance sheet, our term debt Park Medi World Limited August 04, 2026 Page 5 of 18 excluding lease liability stood at Rs.25.6 crores as of 30th June 2026, as
We have added 960 -beds across Bhatinda 250, Agra 360, and Panchkula 350, which entered the denominator immediately while ramping up over several quarters. We expect full-year FY’27 occupancy to moderate from the FY’26 figures of 64%, largely on account of the addition of significant new capacity of 1,490-beds in calendar year 2026. Our Agra facility, commissioned in February 2026, and our Pa nchkula facility, commis
MANAGEMENT PROMISE LEDGER
Quantified statements on the clock
“We have added 960 -beds across Bhatinda 250, Agra 360, and Panchkula 350, which entered the denominator immediately while ramping up over several quarters. We expect full-year FY’27 occupancy to moderate from the FY’26 figures of 64%, largely on account of the addition of significant new capacity of 1,490-beds in calendar year 2026. Our Agra facility, commissioned in February 2026, and our Pa nchkula facility, commis”
HOW TO READ THIS PAGE
Evidence, freshness and limitations
What does the TickerSutra score mean?
The score ranks captured evidence across financial quality, growth, moat and margins, regulatory catalysts, governance, institutional trend and valuation comfort. It is a research-prioritization tool—not a buy recommendation or price target.
Which sources support this page?
Financial history, ownership and pledge data, NSE and BSE filings, annual reports and available earnings-call transcripts are combined here. Use the source trail and original exchange document before relying on a decision-critical fact.
Why can an item be unresolved?
Unresolved means the current captured source window did not provide enough evidence for that check. It does not establish that a risk or relationship is absent.
Maintained by TickerSutra Research · Snapshot updated 29 Sept 2026 · Read the methodology · Read the disclaimer
DIRECTOR & BUSINESS NETWORK
Loading corporate intelligence
Loading universe coverage and exchange-backed evidence…